Other languages Isofol Medical AB

Equities

Delayed Nasdaq Stockholm Other stock markets 05:13:53 2024-04-29 EDT			5-day change	1st Jan Change
0.683 ^SEK	-1.59%		-5.01%	-6.44%

02-20	Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
02-20	Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-20
Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-20
Isofol Medical Hires New CFO	01-11
Isofol Medical Names New CEO	01-09
Isofol Medical AB Announces CEO Changes	01-09
Isofol Medical AB Announces Board Elections	01-04
Isofol Medical AB Presents Additional Results from Laboratory Tests with Arfolitixorin Showing Supplementary Effects	12-28
Isofol Medical AB Appoints Jan-Eric Österlund as Member of the Board	12-13
Isofol Receives the First Results from Laboratory Tests of Arfolitixorin	12-07
Isofol Medical Unit to Face Liquidation	12-01
Isofol Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-10
Isofol Receives Shareholders Request for EGM; Shares Fall	11-09
Isofol Medical AB Announces Appointment of Nomination Committee Members	11-08
Isofol Medical AB Announces Results from the Modelle 001 Study	23-10-05
Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22
Isofol Medical AB Presents Conclusions from the In-Depth Analysis of the AGENT Study	23-07-04
Sweden's Isofol Medical Names Acting CEO	23-06-23
Isofol Medical AB Appoints Roger Tell as Acting CEO	23-06-22
Isofol Medical CEO Steps Down	23-06-22
Isofol Medical AB Announces Resignation of Thomas Andersson as CEO	23-06-21

No results for this search